Summary & Overview
CPT 11646: Excision of Malignant Skin Lesion on Face >4.0 cm
CPT code 11646 designates the surgical excision of a malignant skin lesion larger than 4.0 cm located on high-visibility facial sites — including the face, ears, eyelids, nose, and lips. This code captures a higher-complexity dermatologic oncology procedure where achieving clear margins and preserving form and function are primary clinical goals. Nationally, coding and billing for large facial skin cancer excisions affect surgical practices, hospital outpatient departments, and payer reimbursement patterns for complex dermatologic surgery.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an explanation of the clinical context for use of the code, typical sites of service, and common modifiers associated with surgical procedures. The publication summarizes benchmarking considerations and policy factors that influence coverage and payment for major excisions of malignant lesions on cosmetically and functionally important facial areas. It also outlines what to expect in documentation requirements and coding elements relevant to the procedure. Data not available in the input includes specific ICD-10 diagnoses, payer-specific fee schedules, and associated taxonomy details.
Billing Code Overview
CPT code 11646 describes the excision of a malignant skin lesion, including margins, greater than 4.0 cm in diameter, performed on the face, ears, eyelids, nose, or lips. This procedure involves surgical removal of a cancerous skin tumor with appropriate margins to ensure complete excision.
-
Service type: Surgical excision of a malignant skin lesion
-
Typical site of service: Outpatient surgical center or hospital operating room for procedures on the face, ears, eyelids, nose, or lips
Data not available in the input for associated taxonomies, specific ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient presents to a dermatologic or surgical clinic with a biopsy-confirmed malignant cutaneous tumor (for example, squamous cell carcinoma or basal cell carcinoma) located on the nose measuring greater than 4.0 cm in maximum diameter. The provider evaluates the lesion, reviews the pathology, obtains informed consent, and schedules an excision in an ambulatory surgical center or hospital outpatient department. On the day of service the patient undergoes local anesthesia with sedation or general anesthesia as clinically indicated; the surgeon excises the lesion with appropriate margins and performs necessary reconstruction (primary closure, flap, or graft) to restore form and function of the face. Specimens are labeled and sent to pathology for permanent section analysis. Postoperative instructions and wound care are provided, and follow-up visits are arranged for wound check and pathology review. Typical site of service: outpatient surgical center or hospital outpatient department. Service type: surgical excision of malignant skin lesion with margins on cosmetically and functionally sensitive facial areas.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
50 | Bilateral procedure | Use if identical malignant lesions on symmetric facial sites are excised in the same operative session and payer allows bilateral reporting. |